Naftidrofuryl oxalate(CAS: 3200-06-4)

Naftidrofuryl oxalate (CAS: 3200-06-4) is subject to various regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the EU, and FDA and EPA requirements in the USA. Manufacturers and handlers must comply with these regulations for classification, labeling, and safe handling.

In synthesis, alternatives to Naftidrofuryl oxalate (CAS: 3200-06-4) may include similar compounds or structures that serve similar physiological functions. Common alternatives include isosorbide dinitrate and other vasodilators, which can be used as substitutes based on specific application requirements.

The market for Naftidrofuryl oxalate (CAS: 3200-06-4) is focused on its use as a vasodilator in the treatment of peripheral arterial disease. Research trends are currently exploring its potential in other therapeutic areas, such as cognitive function and cerebrovascular diseases. Market trends show steady demand with price stability due to its established use.

Waste containing Naftidrofuryl oxalate (CAS: 3200-06-4) should be collected in appropriate containers and handled according to local and national hazardous waste regulations. Proper disposal methods include incineration or professional waste disposal services. Environmental protection precautions include ensuring no contamination of water bodies and proper ventilation during handling.